Acquisition Synergy Instat is now part of Veristat, signaling an immediate cross-sell opportunity to expand Veristat's clinical development services into Instat's existing client base and enhance statistical, data management and medical writing capabilities.

Specialized Data Services High value in statistical design, data management and EDC database construction positions Veristat to upsell end-to-end analytics heavy trials, complex data management, and regulatory submission support to biotech and pharma clients seeking integrated CRO solutions.

Mid-market Target With 11-50 employees and revenue in the 10–25 million range, the company operates in the mid-market segment ideal for expanding Veristat’s service footprint through project-based and long-term engagements without enterprise-scale procurement friction.

Tech and Modernization Reliance on modern analytics and EDC capabilities complements Veristat’s existing offerings, presenting a shared value proposition around data integrity, cloud-enabled workflows, and accelerated regulatory submissions to potential clients seeking robust biostatistics and data management.

Collaborative Growth Historical partnerships and performance analytics focus (e.g., coaching and scouting tools in sports analytics) indicate a culture of collaboration; leverage this to position integrated solutions for multi-therapeutic programs and early-phase to phase III studies across potential sponsors.